MARQUITA SMITH: Open Payments
NPI 1790478089 · MANVEL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 42 payments from 11 companies in 2025. Trend: 2023 $93 · 2024 $249 · 2025 $791
Food & beverage: $791
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $238 |
| Novo Nordisk Inc | 13 | $195 |
| Paratek Pharmaceuticals, Inc. | 9 | $148 |
| Lilly USA, LLC | 4 | $84 |
| Dexcom, Inc. | 1 | $23 |
| Corium, LLC | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| Atland Pharmaceuticals, LLC | 1 | $16 |
Products named: NUZYRA, QULIPTA, VRAYLAR, Wegovy, Rybelsus, MOUNJARO, UBRELVY, Ozempic.
Industry payments across TX — which companies pay providers there.
